Itraconazole versus terbinafine (LAMISIL®): Which is better for the treatment of onychomycosis?

Journal of the European Academy of Dermatology and Venereology

Volumn 9, Issue 3, 1997, Pages 215-221

  Honeyman, J F ^a   Talarico Filho, S ^b   Arruda, L H F ^c   Pereira Jr , A C ^d   Santamaria J R ^e   Souza, E M ^f   Woscoff, A ^g   Amorim Filho, R ^e   De La Parra, C R ^a   Enokihara, M Y ^b   Gavazoni, M F ^d   Gubelin, H W ^a   Rosa, S P ^f   Turini, M A G ^f   Vitale, M A ^g  

^a UNIVERSITY OF CHILE   (Chile)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Facultade de Medicina de Jundial ^*  (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e Division of Infectious and Parasitic Diseases Hospital Evangélico de Curitiba   (Brazil)

^f Dr Elemir Macedo de Souza   (Brazil)

^g UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Itraconazole; Onychomycosis; Terbinafine

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ADULT; ANOREXIA; ANTIFUNGAL ACTIVITY; ARTICLE; BULIMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

EID: 6844240880     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00069-X     Document Type: Article

References (19)

1. Piérard GE, Arrese-Estrada J, Piérard-Franchimont C. Treatment of onychomycosis; traditional approaches. J Am Acad Dermatol 1993;29:S41-S45.
2. Hay RJ, Roberts SOB, Mackenzie DWR. Mycology. In Rook GAW, Wilkinson JD, Ebling FJG, eds. Textbook of Dermatology, 5th edn. Oxford: Blackwell Scientific, 1992;1127-1216.
3. Hay RJ. Onychomycosis. Dermatol Clin 1993;11:161-169.
4. Fromtling RA. Overview of medically important antifungal azole derivates. Clin Microbiol Rev 1988;1:187-217.
5. Goodfield MJD. Short-duration therapy with terbinafine for dermatophyte onychomycosis; a multicentric-trial. Br J Dermatol 1992;126(Suppl. 39):33-35.
6. Roseew O, De Doncker P. New therapeutic concepts for the treatment of onychomycosis. J Eur Acad Dermatol Venereal 1993;2(Suppl. 1):S34-S38.
7. Goodfield MJD, Andrew L, Evans EGV. Short term treatment of dermatophyte with terbinafine. Br Med J 1992;304:1151-1154.
8. Grant SM, Clissold P. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989;37:310-344.
9. Zaias N, Drachman D. A method for determination of drug effectiveness in onychomycosis. J Am Acad 1983;9:912-919.
10. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-272.
11. Einarson TR, Arikian SR, Shear NH. Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective. Br J Dermatol 1994;130(Suppl. 43):32-34.
12. Van Der Schroeff JG, Cirkel PKS, Crijns MG et al. A randomized treatment duration-findings study of terbinafine in onychomycosis. Br J Dermatol 1992;126(Suppl. 39):36-39.
13. Davies RR, Everall JD, Hamilton E. Mycological and clinical evaluation of griseofulvin for chronic onychomycosis. Br Med J 1967;3:464-468.
14. Villars VV, Jones TC. Clinical use of oral and topical terbinafine in the treatment of fungal diseases. In Rippon JW, Fromtling RA, eds. Cutaneous Antifungal Agents: Selected Compounds in Clinical Practice and Development. New York: Marcel Dekker, 1993;151-168.
15. Van Cauteren H, Lampo A, Vanderberghe J et al. Toxicological profile and safety evaluation of antifungal azole derivatives. Mycoses 1989;32(Suppl. 1):60-66.
16. Balfour JA, Fauds D. Terbinafine. A review of its pharmacodynamic properties and therapeutic potential in superficial mycoses. Drugs 1992;43:259-284.
17. Morelli R, Stinchi C, La Placa Jr. M et al. Terbinafine versus itraconazole in the treatment of dermatophyte nail infections (abstract). In 12th Congress of the International Society for Human and Animal Mycology (ISHAM), Adelaide, 1994.
18. Arenas R, Dominguez-Cherit J, Fernández ML. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995;34:138-143.
19. Bräutigam M, Nolting S, Schopf RE et al. Randomized double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br Med J 1995;311:919-922.